Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis.
about
Medical therapies for parenteral nutrition-associated cholestasis in term and preterm infantsAlterations in parenteral nutrition management for the treatment of parenteral nutrition-associated cholestasis in term and preterm infantsControversies in the Mechanism of Total Parenteral Nutrition Induced PathologyClinical application of transcriptional activators of bile salt transporters.Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis.Chronic parenteral nutrition induces hepatic inflammation, steatosis, and insulin resistance in neonatal pigs.Total parenteral nutrition-associated cholestasis and risk factors in preterm infants.Specific microbiome changes in a mouse model of parenteral nutrition associated liver injury and intestinal inflammation.Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.The relationship between the parenteral dose of fish oil supplementation and the variation of liver function tests in hospitalized adult patientsVitamin E in New-Generation Lipid Emulsions Protects Against Parenteral Nutrition-Associated Liver Disease in Parenteral Nutrition-Fed Preterm PigsEnteral bile acid treatment improves parenteral nutrition-related liver disease and intestinal mucosal atrophy in neonatal pigs.Comparison of Formulas Based on Lipid Emulsions of Olive Oil, Soybean Oil, or Several Oils for Parenteral Nutrition: A Systematic Review and Meta-AnalysisParenteral nutrition associated cholestasis is earlier, more prolonged and severe in small for gestational age compared with appropriate for gestational age very low birth weight infants.Role of probiotics in short bowel syndrome in infants and children--a systematic review.Fish oil-based lipid emulsions in the treatment of parenteral nutrition-associated liver disease: an ongoing positive experience.Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.Use of Fish Oil-Based Lipid Emulsions in Infants With Intestinal Failure-Associated Liver Disease: A Case Series.New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs.Determination of 7α-OH cholesterol by LC-MS/MS: Application in assessing the activity of CYP7A1 in cholestatic minipigs.Medical update and potential advances in the treatment of pediatric intestinal failure.Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates.Bile acid transporters and regulatory nuclear receptors in the liver and beyondReview and clinical update on parenteral nutrition-associated liver disease.Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease.Conception, Pregnancy, and Lactation Despite Chronic Intestinal Failure Requiring Home Parenteral Nutrition.Cholestatic liver (dys)function during sepsis and other critical illnesses.Abnormal liver function tests in the parenteral nutrition fed patient.Home Parenteral Nutrition: Fat Emulsions and Potential Complications.Incidence and Risk Factors of Parenteral Nutrition-Associated Cholestasis in Omani Neonates: Single centre experienceRetrospective Dual-Center Study of Parenteral Nutrition-Associated Cholestasis in Premature Neonates: 15 Years' Experience.Glucagon-Like Peptide-2 Alters Bile Acid Metabolism in Parenteral Nutrition--Associated Liver Disease.Correlation between mutation of MDR3 gene exon 6 and parenteral nutrition-associated cholestasis of preterm infants.The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: a multiple-variable analysis.A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition.High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis.Effect of parenteral serum plant sterols on liver enzymes and cholesterol metabolism in a patient with short bowel syndrome.Preserved Gut Microbial Diversity Accompanies Upregulation of TGR5 and Hepatobiliary Transporters in Bile Acid-Treated Animals Receiving Parenteral Nutrition.Parenteral Soy Oil and Fish Oil Emulsions: Impact of Dose Restriction on Bile Flow and Brain Size of Parenteral Nutrition-Fed Neonatal Piglets.Preliminary findings of long-term neurodevelopmental outcomes of infants treated with intravenous fat emulsion reduction for the management of parenteral nutrition-associated cholestasis.
P2860
Q24240289-039584BE-1DE8-4A1F-AE67-55F71A039F2CQ24240633-141B4583-32BA-4ABF-8661-5DD340F21134Q26865276-65804FA9-CF4B-4175-A042-CC5B13D0B67FQ33709930-AC0DF678-461A-43DE-8D25-039BC2465564Q33859400-7B62760C-3CB7-4AFA-B0DC-43B6D62701E2Q34308287-6CC39B28-D368-409E-8B80-80D25A842A97Q34335293-3BEB3F56-ECDE-4B1E-99D1-92B1AE9E32E0Q34374168-3080B47C-A23D-4352-80B3-FC5B036B8BD8Q34726758-28EAB0A0-81F2-4AA4-9DC6-DD4FBD873EF0Q35809593-2B9C75F8-544C-4CF6-B994-EC918B89F1F0Q35858834-618235C5-0C63-4DE9-A685-83E0C39B0DC6Q35925160-D8B985BC-0B70-4A07-BE94-B7A74255FF56Q36670975-C1C091EB-94A8-4E05-9D33-F772A8F87381Q36872901-45A954D1-389B-4A7B-911F-972F97E10F11Q36993969-82AE5A30-65D2-48A1-8A3D-200C32738BF3Q37446645-8C53A554-CF67-4906-9A39-E6188C9A9D2CQ37538088-0133345B-EA73-4457-8109-1C193C8B5B2EQ37576936-25465C80-268E-4B54-9D60-414E747FE78AQ37603224-006DBEAD-6CFA-4F27-AF65-FCB91F1FA69AQ37711000-5635BA08-0C92-47AD-8E1E-05F461164F67Q38005027-9B52DC43-6A7B-4B29-A9C8-0982FF7DBC95Q38024333-7A0DAEEE-68F1-4F83-9424-DA594779E15EQ38033967-AB2DB254-0EA5-4A16-8BEB-B3BB8DAB5265Q38054057-3011A6A4-F88B-4735-814D-0E61CB89D1CAQ38178585-863D6665-D2A7-4DFF-8E26-F8D480095E2CQ38383472-5382657E-CE8A-4F70-96B8-8EEB425933FBQ38590747-F85E7B5B-D093-4AAC-8F78-3231F4F6CA66Q38609226-D43FE711-A85C-45E9-9ABB-9E3BB6421E39Q38930002-7A125451-B943-4CE7-BD84-AF7C97EA505EQ38998254-82AEDB6B-47C8-4292-9018-E4137C3B4F4DQ40353357-577B7C12-A774-47CF-B1DA-8FE9E54D6E5DQ40684817-076DB874-55BB-4357-B394-1467DD5C5DBBQ42930772-AD3584B8-E7E9-44A4-9C07-CB40DBD1E6EFQ44698100-9E539585-194B-4F54-9EE8-10E14114D0E2Q45575315-5499E21A-2A1E-439D-9286-648AC170876CQ45935055-F5FCCC09-BDC5-47CF-987F-5BDC4E476C1BQ46444261-0B84E7E4-BFD9-4713-9BF9-7A801B625FB3Q46504486-6B57713D-4A5E-4B99-BC59-0F7F64CC390FQ47429799-C470741B-70D2-4BB0-82D4-F2B9EF267BDAQ50630108-97A521AF-0CCC-4DA8-A022-0988F1FEAC64
P2860
Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mechanisms of disease: update ...... rition associated cholestasis.
@ast
Mechanisms of disease: update ...... rition associated cholestasis.
@en
type
label
Mechanisms of disease: update ...... rition associated cholestasis.
@ast
Mechanisms of disease: update ...... rition associated cholestasis.
@en
prefLabel
Mechanisms of disease: update ...... rition associated cholestasis.
@ast
Mechanisms of disease: update ...... rition associated cholestasis.
@en
P356
P1476
Mechanisms of disease: update ...... rition associated cholestasis.
@en
P2093
Beth A Carter
Robert J Shulman
P2888
P304
P356
10.1038/NCPGASTHEP0796
P407
P577
2007-05-01T00:00:00Z